Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:00
1150.75
-9.65 (-0.83%)
VOLUME 23,516
LIVE
NSE
Aug 22, 15:50
1153.45
-0.8 (-0.07%)
VOLUME 260,176
News on Ajanta Pharma
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sell Ajanta Pharma, PVR; buy Delta Corp: Ashwani Gujral 

2.16 pm | 21 Aug 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one can sell Ajanta Pharma and PVR and buy Delta Corp....

Sell Ajanta Pharma, Balkrishna Industries, IDFC Bank; buy IGL, Colgate: Sukhani 

9.54 am | 21 Aug 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends selling Ajanta Pharma, Balkrishna Industries and IDFC Bank and advises buying Indraprastha Gas and Col...

Ajanta Pharma Q1 net profit falls 21% to Rs 95 cr

2.47 pm | 09 Aug 2017 |  Source: PTI

The company had posted a net profit of Rs 119.55 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing....

Ajanta Pharma: Outcome of board meeting

2.05 pm | 09 Aug 2017 |  Source: Moneycontrol.com

Press Release being issued on the Results for the quarter ended 30th June....

Ajanta Pharma's board meeting on August 09, 2017

4.45 pm | 31 Jul 2017 |  Source: Moneycontrol.com

We hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday, August 09, 2017 at the Registered Office of the Co...

1
Quick Links for Ajanta Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.